Ani Pharmaceuticals ANIP
NASDAQ ANIP
$73.06 +0.43 (+0.60%)
As of: Sep 30, 2026 · 3:46 PM EDT

Ani Pharmaceuticals (ANIP) Receivables - Other (2014)

Updated

Ani Pharmaceuticals' Receivables - Other was $8 million in Q1 2014.

Analysis

Ani Pharmaceuticals (ANIP) Receivables - Other (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Ani Pharmaceuticals 1.73 Bn 512.62 Mn 165.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 8.00 Mn
API Access

Ani Pharmaceuticals Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ANIP&period=max&api_key=YOUR_API_KEY